Skip to main content

Research Interests


Assil's current research revolves around harnessing the therapeutic potential of the PAX3-FOXO1 fusion protein interactome. 

Selected Grants


ZEB2 as a cell fate switch in fusion-positive rhabdomyosarcoma

ResearchPostdoctoral Associate · Awarded by Hyundai Hope on Wheels · 2024 - 2026